Sierra Oncology logo
Sierra Oncology SRRA

Quartalsbericht 2022-Q1
hinzugefügt 16.12.2023

report update icon

Sierra Oncology P/S 2011-2026 | SRRA

P/S Jährlich Sierra Oncology

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 558 - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
558 558 558

P/S anderer Aktien in der Pharmaeinzelhändler

Name P/S Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
BioNTech SE BioNTech SE
BNTX
35.7 $ 91.21 0.03 % $ 27.2 B germanyGermany
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
11 $ 330.79 3.74 % $ 43.3 B usaUSA
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Cerus Corporation Cerus Corporation
CERS
2.12 $ 1.87 0.27 % $ 356 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
10.4 $ 0.46 -13.08 % $ 5.27 M israelIsrael
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
5.16 $ 24.91 0.89 % $ 3.05 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
2.86 $ 10.08 -0.88 % $ 134 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
196 $ 1.59 0.32 % $ 106 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Curis Curis
CRIS
1 $ 0.53 -3.58 % $ 6.98 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
10.5 $ 4.1 -0.85 % $ 438 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
534 $ 37.76 1.42 % $ 3.55 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.25 K $ 49.35 -0.32 % $ 4.44 B schweizSchweiz
CytomX Therapeutics CytomX Therapeutics
CTMX
12.2 $ 4.35 -4.61 % $ 600 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
1.21 K $ 0.88 2.44 % $ 5.92 M usaUSA
Cue Biopharma Cue Biopharma
CUE
1.07 $ 0.17 -6.06 % $ 16.1 M usaUSA
Aravive Aravive
ARAV
6.61 - -13.39 % $ 1.45 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
2.65 $ 8.24 2.55 % $ 226 M israelIsrael
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
3.27 $ 4.13 -32.85 % $ 10.4 M usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
Daré Bioscience Daré Bioscience
DARE
16.4 $ 1.77 1.75 % $ 19.8 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
500 $ 20.47 -2.8 % $ 2.86 B franceFrance
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
AstraZeneca PLC AstraZeneca PLC
AZN
2.17 - - $ 96.9 B britainBritain
Celldex Therapeutics Celldex Therapeutics
CLDX
1.32 K $ 31.46 1.29 % $ 2.09 B usaUSA